Evaluation of the patient with 'rule out myocardial infarction'

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Evaluation in the emergency department of the patient with chest pain remains a common problem. Large numbers of patients are admitted to the hospital because of diagnostic uncertainty. Strategies dealing with this population include risk stratification by clinical presentation, serial cardiac enzyme assays to exclude myocardial infarction, and detection of myocardial ischemia with nuclear scintigraphy or echocardiography. Each of these strategies is rational with specific benefits and weaknesses. Bypassing these steps and performing immediate exercise testing is the newest approach that appears to be safe, timely, and cost-effective.

Original languageEnglish (US)
Pages (from-to)41-45
Number of pages5
JournalArchives of Internal Medicine
Volume156
Issue number1
DOIs
StatePublished - Jan 8 1996

Fingerprint

Myocardial Infarction
Enzyme Assays
Chest Pain
Radionuclide Imaging
Uncertainty
Myocardial Ischemia
Echocardiography
Hospital Emergency Service
Exercise
Costs and Cost Analysis
Population

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Evaluation of the patient with 'rule out myocardial infarction'. / Lewis, William R; Amsterdam, Ezra A.

In: Archives of Internal Medicine, Vol. 156, No. 1, 08.01.1996, p. 41-45.

Research output: Contribution to journalArticle

@article{7a4901bcbaec47a39f24c01e89ea8534,
title = "Evaluation of the patient with 'rule out myocardial infarction'",
abstract = "Evaluation in the emergency department of the patient with chest pain remains a common problem. Large numbers of patients are admitted to the hospital because of diagnostic uncertainty. Strategies dealing with this population include risk stratification by clinical presentation, serial cardiac enzyme assays to exclude myocardial infarction, and detection of myocardial ischemia with nuclear scintigraphy or echocardiography. Each of these strategies is rational with specific benefits and weaknesses. Bypassing these steps and performing immediate exercise testing is the newest approach that appears to be safe, timely, and cost-effective.",
author = "Lewis, {William R} and Amsterdam, {Ezra A}",
year = "1996",
month = "1",
day = "8",
doi = "10.1001/archinte.156.1.41",
language = "English (US)",
volume = "156",
pages = "41--45",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Evaluation of the patient with 'rule out myocardial infarction'

AU - Lewis, William R

AU - Amsterdam, Ezra A

PY - 1996/1/8

Y1 - 1996/1/8

N2 - Evaluation in the emergency department of the patient with chest pain remains a common problem. Large numbers of patients are admitted to the hospital because of diagnostic uncertainty. Strategies dealing with this population include risk stratification by clinical presentation, serial cardiac enzyme assays to exclude myocardial infarction, and detection of myocardial ischemia with nuclear scintigraphy or echocardiography. Each of these strategies is rational with specific benefits and weaknesses. Bypassing these steps and performing immediate exercise testing is the newest approach that appears to be safe, timely, and cost-effective.

AB - Evaluation in the emergency department of the patient with chest pain remains a common problem. Large numbers of patients are admitted to the hospital because of diagnostic uncertainty. Strategies dealing with this population include risk stratification by clinical presentation, serial cardiac enzyme assays to exclude myocardial infarction, and detection of myocardial ischemia with nuclear scintigraphy or echocardiography. Each of these strategies is rational with specific benefits and weaknesses. Bypassing these steps and performing immediate exercise testing is the newest approach that appears to be safe, timely, and cost-effective.

UR - http://www.scopus.com/inward/record.url?scp=0030033175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030033175&partnerID=8YFLogxK

U2 - 10.1001/archinte.156.1.41

DO - 10.1001/archinte.156.1.41

M3 - Article

VL - 156

SP - 41

EP - 45

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 1

ER -